[Reply to Letter to the Editor in Reference to " Clinical and Economic Evaluation of the Introduction of the Combinazion Trametinib + Dabrafenib in the Management of Advanced Melanoma in the Italian market”]. FE 2017, 18 (1). https://doi.org/10.7175/fe.v18i1.1329.